标题
Cancer immunotherapy: a paradigm shift for prostate cancer treatment
作者
关键词
-
出版物
Nature Reviews Urology
Volume 9, Issue 7, Pages 376-385
出版商
Springer Nature
发表日期
2012-05-29
DOI
10.1038/nrurol.2012.106
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The economic burden of prostate cancer
- (2015) Claus G. Roehrborn et al. BJU INTERNATIONAL
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Lifetime economic burden of prostate cancer
- (2011) Michael E Stokes et al. BMC HEALTH SERVICES RESEARCH
- Immunologic biomarkers as correlates of clinical response to cancer immunotherapy
- (2011) Mary L. Disis CANCER IMMUNOLOGY IMMUNOTHERAPY
- Potent Antitumor Immunity Generated by a CD40-Targeted Adenoviral Vaccine
- (2011) B. N. Hangalapura et al. CANCER RESEARCH
- Immunotherapy for Prostate Cancer: Recent Advances, Lessons Learned, and Areas for Further Research
- (2011) J. L. Gulley et al. CLINICAL CANCER RESEARCH
- Prostate Cancer Immunotherapy: Figure 1.
- (2011) Kenneth F. May et al. CLINICAL CANCER RESEARCH
- 10-year safety follow-up in patients with local VEGF gene transfer to ischemic lower limb
- (2011) K Muona et al. GENE THERAPY
- Cancer immunotherapy using recombinantListeria monocytogenes: Transition from bench to clinic
- (2011) Reshma Singh et al. Human vaccines & immunotherapeutics
- Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice
- (2011) Dev Karan et al. Immunotherapy
- Cancer Immunotherapy Comes of Age
- (2011) Suzanne L. Topalian et al. JOURNAL OF CLINICAL ONCOLOGY
- Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
- (2011) Karim Fizazi et al. LANCET
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors
- (2011) Timothy Kottke et al. NATURE MEDICINE
- Expanding Treatment Options for Metastatic Prostate Cancer
- (2011) Emmanuel S. Antonarakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development of a Listeria monocytogenes-based vaccine against hepatocellular carcinoma
- (2011) Y Chen et al. ONCOGENE
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Listeria monocytogenes as a Vector for Anti-Cancer Therapies
- (2010) Mark Tangney et al. CURRENT GENE THERAPY
- Presentation of tumour antigens by dendritic cells and challenges faced
- (2010) Neil C Robson et al. CURRENT OPINION IN IMMUNOLOGY
- CD40-Targeted Recombinant Adenovirus Significantly Enhances the Efficacy of Antitumor Vaccines Based on Dendritic Cells and B Cells
- (2010) Yun-Sun Kim et al. HUMAN GENE THERAPY
- Harnessing human dendritic cell subsets for medicine
- (2010) Hideki Ueno et al. IMMUNOLOGICAL REVIEWS
- Features of the dendritic cell lineage
- (2010) Ralph M. Steinman et al. IMMUNOLOGICAL REVIEWS
- Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Listeria and Salmonella bacterial vectors of tumor-associated antigens for cancer immunotherapy
- (2010) Yvonne Paterson et al. SEMINARS IN IMMUNOLOGY
- Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer
- (2009) James L. Gulley et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Potentiating Endogenous Antitumor Immunity to Prostate Cancer through Combination Immunotherapy with CTLA4 Blockade and GM-CSF
- (2009) L. Fong et al. CANCER RESEARCH
- A Novel Human Her-2/neu Chimeric Molecule Expressed by Listeria monocytogenes Can Elicit Potent HLA-A2 Restricted CD8-positive T cell Responses and Impact the Growth and Spread of Her-2/neu-positive Breast Tumors
- (2009) M. M. Seavey et al. CLINICAL CANCER RESEARCH
- Phase I Clinical Trial of an Adenovirus/Prostate-Specific Antigen Vaccine for Prostate Cancer: Safety and Immunologic Results
- (2009) D. M. Lubaroff et al. CLINICAL CANCER RESEARCH
- Immunotherapeutics in Development for Prostate Cancer
- (2009) A. L. Harzstark et al. ONCOLOGIST
- Anti-CTLA-4 therapy results in higher CD4+ICOShiT cell frequency and IFN-γ levels in both nonmalignant and malignant prostate tissues
- (2009) Hong Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer
- (2009) Sol Kim et al. PROSTATE
- Inflammation in benign prostatic hyperplasia: A 282 patients' immunohistochemical analysis
- (2009) Grégoire Robert et al. PROSTATE
- The first clinical use of a live-attenuated Listeria monocytogenes vaccine: A Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix
- (2009) Paulo Cesar Maciag et al. VACCINE
- Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters
- (2008) Lotte Engell-Noerregaard et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Development of a Listeria monocytogenes based vaccine against prostate cancer
- (2008) Vafa Shahabi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CD54 is a surrogate marker of antigen presenting cell activation
- (2008) N. A. Sheikh et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Prostate stem cell antigen: A prospective therapeutic and diagnostic target
- (2008) Adam B. Raff et al. CANCER LETTERS
- Construction and Characterization of an Attenuated Listeria monocytogenes Strain for Clinical Use in Cancer Immunotherapy
- (2008) A. Wallecha et al. Clinical and Vaccine Immunology
- Biodistribution and Toxicological Safety of Adenovirus Type 5 and Type 35 Vectored Vaccines Against Human Immunodeficiency Virus-1 (HIV-1), Ebola, or Marburg Are Similar Despite Differing Adenovirus Serotype Vector, Manufacturer's Construct, or Gene Inserts
- (2008) Rebecca L. Sheets et al. Journal of Immunotoxicology
- Prostate cancer: genes, environment, immunity and the use of immunotherapy
- (2008) D Karan et al. PROSTATE CANCER AND PROSTATIC DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More